ML339 is a Selective CXCR6 Antagonist
Prostate cancer is cancer that occurs in the prostate. Prostate cancer is the second-leading cause of cancer deaths for men. Especially, Prostate cancer is one of the most common types of cancer. The morbidity/mortality of prostate cancer has increased globally in recent years. The high mortality rate closely associates...